Acesso livre
Acesso livre

Psiquiatria

Estudo afirma que o uso de melatonina para dormir está em alta, apesar dos potenciais prejuízos à saúde.

4 Fev, 2022 | 15:58h

Using melatonin for sleep is on the rise, study says, despite potential health harms – CNN

Estudo original: Trends in Use of Melatonin Supplements Among US Adults, 1999-2018 – JAMA (gratuito por tempo limitado)

Estudo randomizado | Segurança e eficácia da agomelatina em crianças e adolescentes com transtorno depressivo maior que estão recebendo aconselhamento psicológico.

4 Fev, 2022 | 15:52h

Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries – The Lancet Psychiatry (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

 

Comentário de estudo | Rótulos diagnósticos na doença mental: úteis ou prejudiciais?

4 Fev, 2022 | 15:30h

Diagnostic labels: helpful or harmful? – The Mental Elf

Estudo original: How does diagnostic labelling affect social responses to people with mental illness? A systematic review of experimental studies using vignette-based designs – Journal of Mental Health

Conteúdo relacionado: Consequences of a diagnostic label: A systematic scoping review and thematic framework.

Estudo de coorte | Associação de pré-eclâmpsia e complicações perinatais com distúrbios psiquiátricos e de neurodesenvolvimento nos descendentes.

31 Jan, 2022 | 08:24h

Association of Preeclampsia and Perinatal Complications With Offspring Neurodevelopmental and Psychiatric Disorders – JAMA Network Open

Estudo de coorte | Entre sobreviventes de tratamento em UTI para COVID-19, 75% ainda relatam sintomas físicos, mentais e cognitivos depois de 1 ano.

28 Jan, 2022 | 15:45h

Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19 – JAMA

Comentários:

75% of COVID ICU survivors have physical symptoms 1 year on – CIDRAP

Majority of COVID-19 survivors experience health problems one-year post ICU admission – News Medical

Diretrizes sobre tempo de tela e bem-estar digital para bebês, crianças e adolescentes – “Crianças com menos de 2 anos de idade não devem ser expostas a nenhum tipo de tela; já para crianças de 24-59 meses de idade, o tempo de tela deve ser limitado a, no máximo, 1 hora/dia com supervisão e, para crianças de 5-10 anos de idade, menos de 2 horas/dia.”

25 Jan, 2022 | 14:54h

Indian Academy of Pediatrics Guidelines on Screen Time and Digital Wellness in Infants, Children and Adolescents

Diretriz relacionada: Media and Young Minds – American Academy of Pediatrics

Revisão | Diagnóstico e tratamento do distúrbio neurológico funcional.

25 Jan, 2022 | 14:49h

Diagnosis and management of functional neurological disorder – The BMJ

Estudo randomizado | Segurança e eficácia do daridorexante em pacientes com distúrbios de insônia.

25 Jan, 2022 | 14:43h

Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials – The Lancet Neurology (link para o resumo – $ para o texto completo)

Perspectiva | Consequências da COVID-19 para o sistema nervoso.

21 Jan, 2022 | 15:57h

Nervous system consequences of COVID-19 – Science

Conteúdos relacionados:

Perspective | Post-acute neurological consequences of COVID-19: an unequal burden – “COVID-19 and its neurological consequences particularly burden marginalized communities, and so can only be effectively treated by advancing health equity”.

Review: Counting the neurological cost of COVID-19.

Infection with Covid-19 carries a much higher risk of developing neurological complications than Covid-19 vaccines.

M-A: Frequency of Neurologic Manifestations in COVID-19 – up to one-third of patients (89% hospitalized) experienced at least one neurological manifestation.

Neurological Effects of COVID-19 in Children.

Cohort study: Neurological manifestations of SARS-CoV-2 infection in hospitalized children and adolescents in the UK – “around 1 in 20 of children hospitalized with COVID-19 develop brain or nerve complications linked to the viral infection”.

International Registry: Ischemic and hemorrhagic stroke among critically ill patients with Covid-19.

Short review: Neurological complications of COVID-19.

2 new meta-analysis detail neurologic and psychiatric conditions in COVID-19.

M-A: Encephalitis as Neurological Complication of COVID‐19.

Large study finds 1 in 3 Covid-19 survivors have subsequent mental health and neurological conditionsEight out of ten people hospitalized with COVID-19 develop neurological problems – the most common self-reported symptoms included headache (37%) and anosmia or ageusia (26%).

[Preprint] Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies – up to one-third of COVID-19 patients analyzed in this review, 89% of whom were hospitalized, experienced at least one neurological manifestation

 

Comentário no Twitter

 

Revisão sistemática | Em pacientes com doença de Alzheimer e demência vascular com agitação e psicose, antipsicóticos atípicos provavelmente reduzem um pouco a agitação (certeza moderada de evidência), mas podem ter efeito negligenciável sobre a psicose ou o risco de qualquer evento adverso.

21 Jan, 2022 | 15:45h

Antipsychotics for agitation and psychosis in people with Alzheimer’s disease and vascular dementia – Cochrane Library

Resumo: Do antipsychotic medicines reduce  agitated behaviour and psychotic symptoms in people with Alzheimer’s disease and vascular dementia? – Cochrane Library

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.